Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets urged to vaccinate rabbits against RHD-2
RHD2 is a devastating disease that is highly fatal to unvaccinated rabbits.

British Rabbit Council shares its concerns

Vets are being urged to make rabbit hemorrhagic disease type 2 vaccine (RHD-2) part of their core rabbit vaccination programme.

In a letter to Vet Record (Vol 181 No 19), Sarah Elliott of the British Rabbit Council and Richard Saunders of the Rabbit Welfare Association
share their concerns that some vets are telling owners that vaccination is not required.

They write: ‘We have been concerned to hear that, following breeders recommending that newly acquired pet rabbits are taken to their vet for vaccination, some owners are being told that this is not necessary.

‘A recurring conversation at rabbit shows and on public social media has been that pet rabbit owners know nothing about RHD-2 despite having their rabbits vaccinated yearly against myxomatosis and RHD-1.

‘We would also ask that if a breeder approaches a vet to source and provide vaccine for them that you assist with this. Some breeders have a large number of rabbits and we would ask that you offer a site visit to vaccinate their stock.’

RHD2 is a devastating disease that is highly fatal to rabbits that have not been vaccinated. Since it's discovery in the UK in 2010, the disease has spread throughout much of the country and is now more dominant than RHD-1.

In October 2016, following concerns over a lack of vaccine, the European Medicines Agency issued a marketing authorisation for the vaccine ERAVAC to reduce mortality. This was later followed by Filavic, which received its UK licence in April 2017.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.